Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing
Open Access
- 1 November 2016
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 18 (6) , 923-932
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- ACMG clinical laboratory standards for next-generation sequencingGenetics in Medicine, 2013
- Comparison of Sequencing Platforms for Single Nucleotide Variant Calls in a Human SamplePLOS ONE, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1Nature Genetics, 2012
- Summarizing and correcting the GC content bias in high-throughput sequencingNucleic Acids Research, 2012
- A tale of three next generation sequencing platforms: comparison of Ion torrent, pacific biosciences and illumina MiSeq sequencersBMC Genomics, 2012
- A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinomaNature, 2011
- Recurrence and variability of germline EPCAM deletions in Lynch syndromeHuman Mutation, 2011
- Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencingProceedings of the National Academy of Sciences, 2010
- Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working GroupHuman Mutation, 2008